Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 1 | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 3 | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 4 | — | — |
extra dose administered; extra dose administered; Inappropriate schedule of vaccine; This spontaneous report was received from a lawyer and refers to a 12-year-old female patient who was involved in a litigation process regarding quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) (case). All details regarding the patient's medical history, concurrent conditions and concomitant therapies were captured in case. On 12-APR-2005, at the age of 1 month, the patient was vaccinated with the first dose Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (reported as Haemophilus Influenza Type B [Hb]) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) administered for prophylaxis. On 14-JUN-2005, the patient was vaccinated with the third dose Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) administered for prophylaxis (inappropriate schedule of product administration). On 16-AUG-2005, the patient was vaccinated with the second dose Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) administered for prophylaxis (extra dose administered). On 27-JUN-2006, the patient was vaccinated with the third dose Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) administered for prophylaxis (extra dose administered). This was one of several reports regarding the same patient.